Key facts
- EMED (Therapeutic Devices)’s last known valuation is $37.0M (Jul 1997).
- It has raised $30.0M; the latest was Later Stage VC ($8.0M) in Feb 2026.
- Notable investors include Bessemer Venture Partners, SV Health Investors, Boston Millennia Partners, Credit Suisse, Pacific Venture Group.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for EMED (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for EMED (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EMED (Therapeutic Devices)
Manufacturer of home and subcutaneous infusion systems intended to enable independent drug administration outside clinical settings. The company offers mechanical pumps, flow controllers, needle inserters, subcutaneous needle sets, and device development and manufacturing services, enabling patients, clinicians, and pharmaceutical partners to administer biologics and specialty drugs with controlled delivery and treatment continuity.
- Sector
- Healthcare
- HQ
- El Dorado Hills, CA, United States
- Founded
- 1991
- Website
- emedtc.com/
- Ownership
- Privately Held (backing)
EMED (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EMED (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EMED (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.